Stephen W. Webster - 15 Dec 2022 Form 4 Insider Report for TCR2 THERAPEUTICS INC.

Role
Director
Signature
/s/ Margaret Siegel as Attorney-in-Fact
Issuer symbol
N/A
Transactions as of
15 Dec 2022
Net transactions value
$0
Form type
4
Filing time
19 Dec 2022, 16:06:25 UTC
Previous filing
04 Aug 2022
Next filing
01 Jun 2023
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction TCRR Stock Option (Right to Buy) Award $0 +16,800 $0.000000 16,800 15 Dec 2022 Common Stock 16,800 $0.9700 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 25% of this option shall vest and become exercisable on January 1, 2024, with the remainder vesting in twenty-four (24) equal monthly installments thereafter.